iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) saw a large increase in short interest in the month of June. As of June 15th, there was short interest totaling 12,988 shares, an increase of 134.2% from the May 31st total of 5,546 shares. Approximately 8.7% of the company’s shares are short sold. Based on an average daily volume of 2,385 shares, the days-to-cover ratio is currently 5.4 days.

iShares Neuroscience and Healthcare ETF Stock Up 1.3%

Shares of iShares Neuroscience and Healthcare ETF stock traded up $0.49 during trading on Monday, reaching $38.72. 3,661 shares of the company were exchanged, compared to its average volume of 1,991. The business has a 50-day moving average price of $35.19 and a 200-day moving average price of $33.31. The firm has a market capitalization of $5.81 million, a price-to-earnings ratio of 15.61 and a beta of 0.77. iShares Neuroscience and Healthcare ETF has a twelve month low of $21.89 and a twelve month high of $38.84.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.